GASTROINTESTINAL NEUROENDOCRINE CARCINOMA

This adverse event was reported 29 times

GASTROINTESTINAL NEUROENDOCRINE CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LURBINECTEDIN 1 0.0009
1 CALCIFEDIOL 1 0.0004
2 LUTETIUM LU 177 DOTATATE 2 0.0003
3 DAROLUTAMIDE 1 0.0002
4 REPAGLINIDE 1 0.0001
5 EVEROLIMUS TABLETS 2 0.0001
6 OCTREOTIDE ACETATE 3 0.0001
7 PEGFILGRASTIM 1 0.0001
8 PANCRELIPASE 2 0.0001
9 OLAPARIB 1 0.0000
See all drugs enriched for association with GASTROINTESTINAL NEUROENDOCRINE CARCINOMA